PDCD1 and neoplasm: Preclinical data on Lewis lung carcinoma mouse models demonstrated a synergic effect by the combination of anti-PD-1 and endostar (a recombinant humanized endostatin, anti-angiogenic molecule) in suppressing tumor growth by means of improving the TME and activating PI3K/AKT/mTOR-mediated autophagy [153].